BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 24126791)

  • 1. Activation of estrogen receptors with E2 downregulates peroxisome proliferator-activated receptor γ in hepatocellular carcinoma.
    Lin YM; Velmurugan BK; Yeh YL; Tu CC; Ho TJ; Lai TY; Tsai CH; Tsai FJ; Tsai CH; Huang CY
    Oncol Rep; 2013 Dec; 30(6):3027-31. PubMed ID: 24126791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cross-talk between estrogen receptor and peroxisome proliferator-activated receptor gamma in thyroid cancer.
    Chu R; van Hasselt A; Vlantis AC; Ng EK; Liu SY; Fan MD; Ng SK; Chan AB; Liu Z; Li XY; Chen GG
    Cancer; 2014 Jan; 120(1):142-53. PubMed ID: 24114184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of peroxisome proliferator-activated receptor γ inhibits estrogen receptor α transcriptional activity in endometrial carcinoma cells.
    Zhang G; Hou X; Gao S
    Oncol Rep; 2015 Mar; 33(3):1227-34. PubMed ID: 25592200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC; Huang CC; Chang HC; Hu TH; Hung WC
    Clin Cancer Res; 2008 Jul; 14(13):4045-52. PubMed ID: 18593980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
    Cheung KF; Zhao J; Hao Y; Li X; Lowe AW; Cheng AS; Sung JJ; Yu J
    Cancer; 2013 Mar; 119(6):1217-26. PubMed ID: 23212831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor α (ESR1) over-expression mediated apoptosis in Hep3B cells by binding with SP1 proteins.
    Tu CC; Kumar VB; Day CH; Kuo WW; Yeh SP; Chen RJ; Liao CR; Chen HY; Tsai FJ; Wu WJ; Huang CY
    J Mol Endocrinol; 2013; 51(1):203-12. PubMed ID: 23733894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E
    Chang-Lee SN; Hsu HH; Shibu MA; Ho TJ; Tsai CH; Chen MC; Tu CC; Viswanadha VP; Kuo WW; Huang CY
    Pathol Oncol Res; 2017 Jul; 23(3):477-485. PubMed ID: 27757837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
    Schaefer KL; Wada K; Takahashi H; Matsuhashi N; Ohnishi S; Wolfe MM; Turner JR; Nakajima A; Borkan SC; Saubermann LJ
    Cancer Res; 2005 Mar; 65(6):2251-9. PubMed ID: 15781638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor gamma in human breast carcinoma: a modulator of estrogenic actions.
    Suzuki T; Hayashi S; Miki Y; Nakamura Y; Moriya T; Sugawara A; Ishida T; Ohuchi N; Sasano H
    Endocr Relat Cancer; 2006 Mar; 13(1):233-50. PubMed ID: 16601291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen receptor expression in chronic hepatitis C and hepatocellular carcinoma pathogenesis.
    Iyer JK; Kalra M; Kaul A; Payton ME; Kaul R
    World J Gastroenterol; 2017 Oct; 23(37):6802-6816. PubMed ID: 29085224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression.
    Miceli V; Cocciadiferro L; Fregapane M; Zarcone M; Montalto G; Polito LM; Agostara B; Granata OM; Carruba G
    OMICS; 2011 May; 15(5):313-7. PubMed ID: 21348637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
    Yu J; Shen B; Chu ES; Teoh N; Cheung KF; Wu CW; Wang S; Lam CN; Feng H; Zhao J; Cheng AS; To KF; Chan HL; Sung JJ
    Hepatology; 2010 Jun; 51(6):2008-19. PubMed ID: 20512989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
    Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
    Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma.
    Rumi MA; Sato H; Ishihara S; Kawashima K; Hamamoto S; Kazumori H; Okuyama T; Fukuda R; Nagasue N; Kinoshita Y
    Br J Cancer; 2001 Jun; 84(12):1640-7. PubMed ID: 11401318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma.
    Nojima H; Kuboki S; Shinoda K; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takayashiki T; Miyazaki M
    J Hepatobiliary Pancreat Sci; 2016 Sep; 23(9):574-84. PubMed ID: 27451128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fenofibrate induced PPAR alpha expression was attenuated by oestrogen receptor alpha overexpression in Hep3B cells.
    Jeng LB; Velmurugan BK; Hsu HH; Wen SY; Shen CY; Lin CH; Lin YM; Chen RJ; Kuo WW; Huang CY
    Environ Toxicol; 2018 Feb; 33(2):234-247. PubMed ID: 29134746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
    Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
    Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the pesticides prochloraz and methiocarb on human estrogen receptor alpha and beta mRNA levels analyzed by on-line RT-PCR.
    Hofmeister MV; Bonefeld-Jørgensen EC
    Toxicol In Vitro; 2004 Aug; 18(4):427-33. PubMed ID: 15130599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.
    Pang X; Wei Y; Zhang Y; Zhang M; Lu Y; Shen P
    Cancer Sci; 2013 Jun; 104(6):672-80. PubMed ID: 23461356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.